Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin

被引：0
|
作者：
Mück W. [1 ,2 ]
Adelmann H.-G. [1 ]
Ruf T. [1 ]
Unger S. [1 ]
Voith B. [1 ]
机构：
[1] Institute of Clinical Pharmacology, Bayer AG, Wuppertal
[2] Institute of Clinical Pharmacology, Bayer AG, Pharma Research Center, D-42096 Wuppertal, Aprather Weg
来源：
Clinical Drug Investigation | 2000年 / 19卷 / 1期
关键词：
Pravastatin; Orlistat; Cerivastatin; Maximum Observe Plasma Concentration; Reduce Serum Cholesterol Level;
D O I：
10.2165/00044011-200019010-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：71 / 73
页数：2
相关论文
共 50 条
  • [21] Assessment of Pharmacokinetic Drug-Drug Interaction Between Pradigastat and Atazanavir or Probenecid
    Mendonza, Anisha
    Hanna, Imad
    Meyers, Dan
    Koo, Phillip
    Neelakantham, Srikanth
    Zhu, Bing
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 355 - 364
  • [22] Pharmacokinetic drug-drug interaction between clozapine and brexpiprazole: A case series
    Cereda, G.
    Lazzaretti, M.
    Colli, C.
    Fontana, E.
    Enrico, P.
    Pigoni, A.
    Baldelli, S.
    Cattaneo, D.
    Clementi, E.
    Brambilla, P.
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 261 : 15 - 17
  • [23] Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model
    Kawuma, Aida N. N.
    Wasmann, Roeland E. E.
    Dooley, Kelly E. E.
    Maartens, Gary
    Denti, Paolo
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) : 1216 - 1221
  • [24] Pharmacokinetic drug-drug interaction between olaparib and apixaban: a case report
    Berge, M.
    Giraud, J. S.
    De Percin, S.
    Puszkiel, A.
    Thomas-Schoemann, A.
    Blanchet, B.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (05) : 519 - 521
  • [25] Pharmacokinetic Drug-Drug Interaction and Responsible Mechanism between Memantine and Cimetidine
    Choi, Young A.
    Song, Im-Sook
    Choi, Min-Koo
    [J]. PHARMACEUTICS, 2018, 10 (03):
  • [26] Amiodarone/AntithromboticsBleeding and drug-drug pharmacokinetic interaction
    [J]. Reactions Weekly, 2024, 2000 (1) : 26 - 26
  • [27] Lack of drug-drug interaction between esomeprazole and rofecoxib in healthy subjects
    Hassan-Alin, M
    Nilsson-Pieschl, C
    Naesdal, J
    Langstrom, G
    Lundgren, M
    Nyman, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 399 - 399
  • [28] Lack of drug-drug interaction between esomeprazole and naproxen in healthy subjects
    Hassan-Alin, M
    Nilsson-Pieschl, N
    Naesdal, J
    Langstrom, G
    Lundgren, M
    Nyman, L
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A541 - A541
  • [29] Lack of drug-drug interaction between esomeprazole and naproxen in healthy subjects
    Hassan-Alin, M
    Nilsson-Pieschl, C
    Naesdal, J
    Langstrom, G
    Lundgren, M
    Nyman, L
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 398 - 399
  • [30] Evidence of a Drug-Drug Interaction Linked to Inhibition of Ester Hydrolysis by Orlistat
    Bentley, Darren
    Young, Anne-Marie
    Rowell, Lucy
    Gross, Guenter
    Tardio, Joseph
    Carlile, David
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (04) : 390 - 396
12345